Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Latanoprost Versus Tafluprost: 24-hour Intraocular Pressure (IOP) (SAF-24H-IOP)

This study has been completed.
Aristotle University Of Thessaloniki
Information provided by (Responsible Party):
Luciano Quaranta, MD, Azienda Ospedaliera Spedali Civili di Brescia Identifier:
First received: July 13, 2010
Last updated: May 5, 2013
Last verified: May 2013